Click on a filter below to refine your search. Remove a filter to broaden your search.
Of the few that had moderate-certainty evidence, beneficial associations with pain were seen.
Hospital-onset SARS-CoV-2 remained associated with increased morbidity and mortality during the omicron era.
Medical debt also was tied to delayed or forgone healthcare.
Excellent tolerability was seen, with no changes in blood pressure, minimal reports of sedation and minimal dissociation.
The findings were independent of chemotherapy-induced inflammation.
CYP2D6-inhibiting antidepressants were linked to worse outcomes than CYP2D6-neutral antidepressants when used with CYP2D6-metabolizing opioids.
Higher adherence was tied to lower inflammatory marker levels over time.
Benefits were seen for sleep period and total sleep time but not for sleep quality.
Improvements were seen in maximal oxygen consumption and oxygen consumption at the first ventilatory threshold.
An increased likelihood was seen for female physicians, older physicians, and trainees, and for emergency department doctors.